Patents by Inventor Kaori Teshima

Kaori Teshima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutically stable hemostatic compositions
    Patent number: 7329724
    Abstract: A novel hemostatic composition and a hemostatic pharmaceutical preparation are provided. A pharmaceutically stable hemostatic liquid composition comprising a mixed solution of activated blood coagulation factor VII (FVIIa) and blood coagulation factor X (FX) in a single container. The mixed solution is maintained at pH ranging from 5.0 to 6.5.
    Type: Grant
    Filed: July 10, 2002
    Date of Patent: February 12, 2008
    Assignee: Juridical Foundation the Chemo-Sero-Therapeutic Research Institute
    Inventors: Tatsuya Araki, Kazuhiko Tomokiyo, Yasushi Nakatomi, Kaori Teshima, Tomohiro Nakagaki
  • Medicinal compositions for preventing and treating hemorrhagic diseases associating thrombopathy
    Patent number: 7033994
    Abstract: The present invention provides a pharmaceutical composition for treatment and prevention of bleeding disorders caused by platelet disorders, not caused by defect in blood coagulation factors or von Willebrand Factor but caused by reduction of circulating platelet count or platelet dysfunction, said composition comprising a hemostatic effective amount of Factor VIII and/or von Willebrand Factor. Also provided is a method for treating said bleeding, comprising administering a hemostatic effective amount of Factor VIII and/or von Willebrand Factor to patients suffering from bleeding disorders caused by platelet disorders.
    Type: Grant
    Filed: December 21, 2000
    Date of Patent: April 25, 2006
    Inventors: Tatsuya Araki, Kazuhiko Tomokiyo, Yasushi Nakatomi, Kaori Teshima, Tomoko Watanabe, Tomohiro Nakagaki
  • Medicinal compositions for treating and preventing diseases based on abnormal blood coagulation
    Patent number: 6881721
    Abstract: The present invention provides a pharmaceutical composition for treatment and prevention of hemorrhage associated with blood coagulation disorders, comprising activated Factor VII (FVIIa) and Factor X (FX) as an active ingredient. The pharmaceutical composition of the present invention contains no components causative side effects, is safe, highly efficacious, and easy to manage hemostasis. The pharmaceutical composition can be used for hemostatic management of patients suffering from hemorrhage associated with blood coagulation disorders, for example, disorders (including deficiency) of blood coagulation factors, especially caused by inhibitors (antibodies) against blood coagulation factors.
    Type: Grant
    Filed: December 21, 2000
    Date of Patent: April 19, 2005
    Assignee: Juridical Foundation the Chemo-Sero-Therapeutic Research Institute
    Inventors: Yasushi Nakatomi, Kazuhiko Tomokiyo, Tatsuya Araki, Kaori Teshima, Tomoko Watanabe, Tomohiro Nakagaki
  • Pharmaceutically stable hemostatic compositions
    Publication number: 20040147439
    Abstract: A novel hemostatic composition and a hemostatic pharmaceutical preparation are provided. A pharmaceutically stable hemostatic liquid composition comprising a mixed solution of activated blood coagulation factor VII (FVIIa) and blood coagulation factor X (FX) in a single container. The mixed solution is maintained at pH ranging from 5.0 to 6.5.
    Type: Application
    Filed: January 12, 2004
    Publication date: July 29, 2004
    Inventors: Tatsuya Araki, Kazuhiko Tomokiyo, Yasushi Nakatomi, Kaori Teshima, Tomohiro Nakagaki
  • Medicinal compositions for preventing and treating hemorrhagic diseases associating thrombopathy
    Publication number: 20030125250
    Abstract: The present invention provides a pharmaceutical composition for treatment and prevention of bleeding disorders caused by platelet disorders, not caused by defect in blood coagulation factors or von Willebrand Factor but caused by reduction of circulating platelet count or platelet dysfunction, said composition comprising a hemostatic effective amount of Factor VIII and/or von Willebrand Factor. Also provided is a method for treating said bleeding, comprising administering a hemostatic effective amount of Factor VIII and/or von Willebrand Factor to patients suffering from bleeding disorders caused by platelet disorders.
    Type: Application
    Filed: August 21, 2002
    Publication date: July 3, 2003
    Inventors: Tatsuya Araki, Kazuhiko Tomokiyo, Yasushi Nakatomi, Kaori Teshima, Tomoko Watanabe, Tomohiro Nakagaki
  • Medicinal compositions for treating and preventing diseases based on abnormal blood coagulation
    Publication number: 20030060411
    Abstract: The present invention provides a pharmaceutical composition for treatment and prevention of hemorrhage associated with blood coagulation disorders, comprising activated Factor VII (FVIIa) and Factor X (FX) as an active ingredient. The pharmaceutical composition of the present invention contains no components causative side effects, is safe, highly efficacious, and easy to manage hemostasis. The pharmaceutical composition can be used for hemostatic management of patients suffering from hemorrhage associated with blood coagulation disorders, for example, disorders (including deficiency) of blood coagulation factors, especially caused by inhibitors (antibodies) against blood coagulation factors.
    Type: Application
    Filed: August 20, 2002
    Publication date: March 27, 2003
    Inventors: Yasushi Nakatomi, kazuhiko Tomokiyo, Tatsuya Araki, Kaori Teshima, Tomoko Watanabe, Tomohiro Nakagaki